EurekAlert! -
24 Jun 2021 06:00
(Institute of Cancer Research) A new study could lead to improved decision making in assigning treatments for children with the aggressive cancer rhabdomyosarcoma after revealing key genetic changes underlying development of the disease.
Share this Article